. . . . . . . "[In patients with detected hotspot TP53 mutant advanced solid tumors (n = 11), the treatment led to a 45% rate of SD ?6 months/PR (1 PR and 3 SD ?6 months), median PFS of 3.5 months, and median OS of 12.7 months, compared favorably with the results for patients with undetected hotspot TP53 mutations (n = 25): 16% (1 PR and 3 SD ?6 months, P = 0.096), 2.0 months (P = 0.042), and 7.4 months (P = 0.1), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:16:58+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .